One dividend stock I’d buy today, and one I’d sell

The best dividend shares to buy are ones with sustainable payouts.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Do you have trouble deciding whether to chase dividends or seek capital growth? Why choose when you can have both.

The recruitment business is cyclical, and that’s a good reason to look for sustainable dividends even through earnings downturns.

SThree (LSE: STHR) has kept its ordinary dividends at 14p per share right through the mini-downturn that hit in 2012 and 2013, even when it wasn’t covered by earnings in 2013 – and in better times it has paid a special dividend too. The ordinary dividend yield has been pretty good, running between 4.3% and 4.6% over the past five years. And though there’s no dividend uplift expected this year or next, on today’s share price of 309p we’d still be seeing respectable yields of 4.5%.

Growth too

What about growth? From 2014 onwards, EPS has been picking up again, rising from 16.8p per share in 2011 before the dip, to 23.2p in 2016, for overall growth of 38%.

The combination of reliable dividends and steady long-term earnings growth (despite short-term ups and downs) has helped the share price gain 43% over the past five years, and that’s added a bit over 30% to overall returns.

Forecasts for further EPS growth this year and next drop the forward P/E to less than 12.5 by 2018. And if it comes off then I reckon we’re looking at an attractive price right now – a below-average P/E for an above-average dividend yield.

And though UK gross profit for the first quarter this year was hit by the Brexit fallout, strong performances in the USA and continental Europe helped keep overall gross profit flat.

SThree looks like a solid long-term investment to me, at an attractive price.

Unsustainable

JZ Capital Partners (LSE: JZCP) saw its previous earnings growth come off the rails after 2014,  resulting in an EPS crash from 44.9 cents to just 6.7 cents for the year to February 2017. There are no consensus forecasts now, but at a share price of 558p, that represents a trailing P/E of 106!

JZ, which invests in US and European micro-cap companies and US real estate, cut its dividend by half this year – while switching its redistribution strategy to buying up its own shares when conditions are favourable. Though we still saw a yield of 2.3%, that’s not very impressive and to invest today I’d want to see clear evidence of some serious earnings growth in the medium term.

Latest update

The company’s first-quarter update on Thursday didn’t do a lot to change my mind. JZ reported a fall in net asset value (NAV) to $833.3m, from $848.8m at the end of the last full year, dropping NAV per share to $9.93. Admittedly, at the equivalent of around 766p, that exceeds the current share price of 558p and so the shares are trading at a discount.

But putting aside real estate, asset values of investments in companies, especially micro-cap ones, can be notoriously difficult to assess accurately.

Having said that, the company does appear to be in a net investing phase at the moment, having ploughed $43.9m into investments during the quarter, against only $16.3m realised from disposals. And earnings will surely be erratic over the long term, as it can take some time for an investment in the kinds of assets JZ goes for to come good.

But for me, there’s just too much uncertainty to consider buying at today’s price levels.

Alan Oscroft has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Are Tesco shares easy money heading into 2026?

The supermarket industry is known for low margins and intense competition. But analysts are bullish on Tesco shares – and…

Read more »

Smiling black woman showing e-ticket on smartphone to white male attendant at airport
Investing Articles

Can this airline stock beat the FTSE 100 again in 2026?

After outperforming the FTSE 100 in 2025, International Consolidated Airlines Group has a promising plan to make its business more…

Read more »

Investing Articles

1 Stocks and Shares ISA mistake that will make me a better investor in 2026

All investors make mistakes. The best ones learn from them. That’s Stephen Wright’s plan to maximise returns from his Stocks…

Read more »

Portrait Of Senior Couple Climbing Hill On Hike Through Countryside In Lake District UK Together
Investing Articles

I asked ChatGPT if £20,000 would work harder in an ISA or SIPP in 2026 and it said…

Investors have two tax-efficient ways to build wealth, either in a Stocks and Shares ISA or SIPP. Harvey Jones asked…

Read more »

Investing Articles

How much would I need invested in an ISA to earn £2,417 a month in passive income?

This writer runs the numbers to see what it takes in an ISA to reach £2,417 a month in passive…

Read more »

Investing Articles

Rolls-Royce shares or Melrose Industries: Which one is better value for 2026?

Rolls-Royce shares surged in 2025, surpassing most expectations. Dr James Fox considers whether it offers better value than peer Melrose.

Read more »

Investing Articles

3 top Vanguard ETFs to consider for an ISA or SIPP in 2026

Edward Sheldon believes that these three Vanguard ETFs could be solid investments for a pension (SIPP) or investment account in…

Read more »

Investing Articles

5 growth stocks on Dr James Fox’s watchlist for 2026

Dr James Fox believes these UK and US growth stocks are worth considering as he looks to outperform the stock…

Read more »